Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark

Detalles Bibliográficos
Autores principales: Aksan, Ayşegül, Dignass, Axel, Stein, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822858/
https://www.ncbi.nlm.nih.gov/pubmed/31154627
http://dx.doi.org/10.1007/s12325-019-00990-x
_version_ 1783464423857324032
author Aksan, Ayşegül
Dignass, Axel
Stein, Jürgen
author_facet Aksan, Ayşegül
Dignass, Axel
Stein, Jürgen
author_sort Aksan, Ayşegül
collection PubMed
description
format Online
Article
Text
id pubmed-6822858
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-68228582019-11-06 Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark Aksan, Ayşegül Dignass, Axel Stein, Jürgen Adv Ther Letter Springer Healthcare 2019-06-01 2019 /pmc/articles/PMC6822858/ /pubmed/31154627 http://dx.doi.org/10.1007/s12325-019-00990-x Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Letter
Aksan, Ayşegül
Dignass, Axel
Stein, Jürgen
Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
title Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
title_full Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
title_fullStr Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
title_full_unstemmed Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
title_short Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
title_sort letter: an economic evaluation of iron isomaltoside 1000 versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in denmark
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822858/
https://www.ncbi.nlm.nih.gov/pubmed/31154627
http://dx.doi.org/10.1007/s12325-019-00990-x
work_keys_str_mv AT aksanaysegul letteraneconomicevaluationofironisomaltoside1000versusferriccarboxymaltoseinpatientswithinflammatoryboweldiseaseandirondeficiencyanemiaindenmark
AT dignassaxel letteraneconomicevaluationofironisomaltoside1000versusferriccarboxymaltoseinpatientswithinflammatoryboweldiseaseandirondeficiencyanemiaindenmark
AT steinjurgen letteraneconomicevaluationofironisomaltoside1000versusferriccarboxymaltoseinpatientswithinflammatoryboweldiseaseandirondeficiencyanemiaindenmark

Ejemplares similares